AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

4.340

-0.020-0.46%

Volume:5.09M

Turnover:22.71M

Market Cap:2.61B

PE:-11.39

High:4.590

Open:4.370

Low:4.340

Close:4.360

52wk High:7.550

52wk Low:1.400

Shares:601.57M

Float Shares:377.76M

Volume Ratio:1.31

T/O Rate:1.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.381

EPS(LYR):-0.381

ROE:-174.43%

ROA:-15.61%

PB:15.34

PE(LYR):-11.39

Loading ...

Overview Company News Filings

4DMedical - Acquisition Terms Include a$18.56 Mln Cash, 56,235 Shares, up to 2.59 Mln Options

THOMSON REUTERS

Assessing 4DMedical's Valuation As CT:VQ Clinical Use Call Draws Fresh Attention

Simply Wall St.

ASX Biggest Gainers

MT Newswires Live

4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%

MT Newswires Live

Stock Track | 4DMedical Soars 8.08% Intraday on US Outpatient Market Expansion Through Simonmed's Network

4DMedical Ltd - Ct:Vq Enters US Outpatient Market via Simonmed's 170-Site Network

THOMSON REUTERS

Is 4DMedical’s (ASX:4DX) CT:VQ Push Reframing Its Edge In Respiratory Imaging Adoption?

Simply Wall St.

Stock Track | 4DMedical Soars 8.00% Intraday on Positive Study Results for CT:VQ Imaging Product

4DMedical Says Study Shows CT:VQ Imaging Product Lifts Lung Surgery Response Rate to 76%; Shares Up 3%

MT Newswires Live

Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies

Simply Wall St.

Is 4DMedical’s (ASX:4DX) CT:VQ Push and Index Debut Reframing Its Risk‑Reward Profile?

Simply Wall St.

Is 4DMedical’s (ASX:4DX) GSK Imaging Deal a Clue to Its Evolving Business Model?

Simply Wall St.

A Look At 4DMedical’s Valuation After New GlaxoSmithKline Imaging Contract

Simply Wall St.

4DMedical's Year-to-Date Fiscal 2026 Operating Revenue Rises 12% Year on Year

MT Newswires Live

4DMedical Says State Street Becomes Substantial Holder

MT Newswires Live

A Look At 4DMedical’s (ASX:4DX) Valuation After Its New GlaxoSmithKline Lung Imaging Contract

Simply Wall St.

Is 4DMedical's (ASX:4DX) ASX 200 Debut a Turning Point in Its Risk Narrative?

Simply Wall St.

BRIEF-4Dmedical Executes Contract With Glaxosmithkline For Lung Imaging Analytics

4DMedical Secures One-Year Deal With GlaxoSmithKline

MT Newswires Live

Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/4DX.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":4.34,"timestamp":1790921520000,"preClose":4.36,"halted":0,"volume":5088346,"delay":0,"changeRate":-0.0045871559633028575,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":601571602,"eps":-0.380983,"marketStatus":"Market Closed","change":-0.02,"latestTime":"10-02 16:12:00 AEST","open":4.37,"high":4.59,"low":4.34,"amount":22714765,"amplitude":0.057339,"askPrice":4.38,"askSize":200,"bidPrice":4.34,"bidSize":2304,"shortable":3,"etf":0,"ttmEps":-0.380983,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791154800000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":4.36,"openAndCloseTimeList":[[1790899200000,1790920800000]],"volumeRatio":1.314157,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":4.36,"auctionPrice":4.34,"auctionVolume":203990,"auction":3,"marketStatus":"盘后竞价","timestamp":1790921417000}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-15.61%","roe":"-174.43%","lyrEps":-0.380983,"volumeRatio":1.314157,"shares":601571602,"dividePrice":0,"high":4.59,"amplitude":0.057339,"preClose":4.36,"low":4.34,"week52Low":1.4,"pbRate":"15.34","psRate":"369.72","week52High":7.55,"institutionHeld":0,"latestPrice":4.34,"committee":0.840256,"eps":-0.380983,"divideRate":0,"volume":5088346,"delay":0,"ttmEps":-0.380983,"open":4.37,"prevYearClose":3.93,"prevWeekClose":4,"prevMonthClose":4.25,"prevQuarterClose":4.25,"fiveDayClose":4,"twentyDayClose":3.6,"sixtyDayClose":3.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640899509","title":"4DMedical - Acquisition Terms Include a$18.56 Mln Cash, 56,235 Shares, up to 2.59 Mln Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2640899509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640899509?lang=en_us&edition=fundamental","pubTime":"2026-06-01 07:32","pubTimestamp":1780270322,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUENYJK0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639715988","title":"Assessing 4DMedical's Valuation As CT:VQ Clinical Use Call Draws Fresh Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2639715988","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639715988?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:08","pubTimestamp":1780232909,"startTime":"0","endTime":"0","summary":"4DMedical special call puts CT:VQ clinical use in focus\n4DMedical (ASX:4DX) is drawing fresh attention after scheduling a special call to present on the clinical use of its CT:VQ non contrast post processing technology, spotlighting how this lung imaging software might fit into everyday healthcare workflows.\nSee our latest analysis for 4DMedical.\nThe A$3.97 share price has moved sharply around this news, with an 18.86% 1 day share price return and 9.67% 7 day share price return, in contrast...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-as-ctvq-clinical-use-call-dra","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-as-ctvq-clinical-use-call-dra","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639432006","title":"ASX Biggest Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639432006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639432006?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:55","pubTimestamp":1780023344,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest gains on Friday.Electro Optic Systems : +15%, AU$11Elsight : +13%, AU$7.184DMedical : +12%, AU$3.74Judocapitol FP : +11%, AU$1.54Flight Centre Travel Group : +8%, AU$10.96West African Resources : +8%, AU$3.19Lindian Resources : +8%, AU$0.83Ora Banda Mining : +7%, AU$1.36Vulcan Energy Resources : +7%, AU$3.89Westgold Resources : +6%, AU$5.18","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","ELS.AU","OBM.AU","LIN.AU","FLT.AU","VUL.AU","WAF.AU","EOS.AU","4DX.AU","BK7115","WGX.AU","BK7506","BK7104","BK7084","BK7070","BK7094","BK7504","BK7135","JDO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648374","title":"4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648374","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639648374?lang=en_us&edition=fundamental","pubTime":"2026-05-29 09:40","pubTimestamp":1780018807,"startTime":"0","endTime":"0","summary":"4DMedical  struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.\"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity,\" the company said.The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.4DMedical shares surged 11% in recent Friday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189474019","title":"Stock Track | 4DMedical Soars 8.08% Intraday on US Outpatient Market Expansion Through Simonmed's Network","url":"https://stock-news.laohu8.com/highlight/detail?id=1189474019","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189474019?lang=en_us&edition=fundamental","pubTime":"2026-05-29 08:16","pubTimestamp":1780013785,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock soared 8.08% during intraday trading on Friday, following the company's announcement of a significant market expansion.The medical technology company has entered the US...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639612102","title":"4DMedical Ltd - Ct:Vq Enters US Outpatient Market via Simonmed's 170-Site Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2639612102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639612102?lang=en_us&edition=fundamental","pubTime":"2026-05-29 08:04","pubTimestamp":1780013055,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4250WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637730351","title":"Is 4DMedical’s (ASX:4DX) CT:VQ Push Reframing Its Edge In Respiratory Imaging Adoption?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637730351","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637730351?lang=en_us&edition=fundamental","pubTime":"2026-05-24 17:18","pubTimestamp":1779614323,"startTime":"0","endTime":"0","summary":"Earlier this month, 4DMedical Limited presented on the clinical use of its CT:VQ technology, highlighting its advanced respiratory imaging capabilities and potential role alongside existing lung function assessments.\nThis focus on real-world clinical application offers investors a clearer view of how 4DMedical’s CT:VQ platform could fit into everyday hospital workflows and diagnostic decision-making.\nWe’ll now examine how this emphasis on CT:VQ’s clinical use may influence 4DMedical’s...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-ctvq-push-reframing-its-edge-in-respira","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-ctvq-push-reframing-its-edge-in-respira","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188640825","title":"Stock Track | 4DMedical Soars 8.00% Intraday on Positive Study Results for CT:VQ Imaging Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1188640825","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188640825?lang=en_us&edition=fundamental","pubTime":"2026-05-19 08:40","pubTimestamp":1779151230,"startTime":"0","endTime":"0","summary":"4DMEDICAL LTD (ASX:4DX) saw its shares soar 8.00% during intraday trading on Tuesday, following the announcement of positive clinical study results.The surge comes after the company disclosed that a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636400005","title":"4DMedical Says Study Shows CT:VQ Imaging Product Lifts Lung Surgery Response Rate to 76%; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636400005","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636400005?lang=en_us&edition=fundamental","pubTime":"2026-05-19 08:37","pubTimestamp":1779151030,"startTime":"0","endTime":"0","summary":"4DMedical  said a study evaluating its CT:VQ imaging product, published in the American Journal of Respiratory and Critical Care Medicine, shows that CT:VQ-guided patient selection would deliver a 76% response rate to lung volume reduction surgery , compared with the current rate of 46%, according to a Tuesday Australian bourse filing.The company said CT:VQ derives functional ventilation and perfusion information from existing non-contrast CT scans, with improved pre-operative patient selection strengthening the economics of LVRS programs for hospitals by concentrating surgical resources on patients most likely to benefit.The company's shares were up 3% in recent Tuesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635065547","title":"Assessing 4DMedical’s Valuation After New GSK Contract And Rising Interest In Lung Imaging Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635065547","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635065547?lang=en_us&edition=fundamental","pubTime":"2026-05-16 19:40","pubTimestamp":1778931634,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) is back in focus after securing a one year contract with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development, while its respiratory imaging technologies draw heightened investor attention.\nSee our latest analysis for 4DMedical.\nThe GSK contract has arrived at a time when momentum around the stock is shifting again, with the share price up 8.88% in the last day and 29.91% over the week, but down 34.12% over 30 days, while very large...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedicals-valuation-after-new-gsk-contract-and-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","4DX.AU","GSK.UK","GSKH","BK4532","BK4585","BK4007","GSK","LU1829250122.USD","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634251605","title":"Is 4DMedical’s (ASX:4DX) CT:VQ Push and Index Debut Reframing Its Risk‑Reward Profile?","url":"https://stock-news.laohu8.com/highlight/detail?id=2634251605","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634251605?lang=en_us&edition=fundamental","pubTime":"2026-05-12 07:25","pubTimestamp":1778541936,"startTime":"0","endTime":"0","summary":"In recent trading, 4DMedical has continued to attract attention as investors respond to ongoing operational and regulatory progress, particularly around its CT:VQ respiratory imaging technology and expanded commercial footprint.\nThis momentum has been underpinned by 4DMedical’s entry into the S&P/ASX 200 index and its sizeable recent capital raisings, which have opened the door to greater institutional participation and supported its international expansion plans.\nWe’ll now examine how the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-ctvq-push-and-index-debut-reframing-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-ctvq-push-and-index-debut-reframing-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632960372","title":"Is 4DMedical’s (ASX:4DX) GSK Imaging Deal a Clue to Its Evolving Business Model?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632960372","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632960372?lang=en_us&edition=fundamental","pubTime":"2026-05-03 07:24","pubTimestamp":1777764264,"startTime":"0","endTime":"0","summary":"4DMedical Limited recently announced a one-year contractual engagement, commencing 1 May 2026, to provide its proprietary quantitative lung imaging analytics to GlaxoSmithKline, in association with Flywheel Exchange, in support of pulmonary drug development and clinical research.\nThis agreement with one of the world’s large pharmaceutical companies adds to 4DMedical’s existing biopharma relationships and underlines growing use of its lung imaging platform in clinical trials.\nWe’ll now...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-gsk-imaging-deal-a-clue-to-its-evolving","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-gsk-imaging-deal-a-clue-to-its-evolving","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSK","4DX.AU","LU1829250122.USD","BK4585","BK4532","BK4007","BK7094","GSKH","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632097615","title":"A Look At 4DMedical’s Valuation After New GlaxoSmithKline Imaging Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2632097615","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632097615?lang=en_us&edition=fundamental","pubTime":"2026-05-01 14:51","pubTimestamp":1777618302,"startTime":"0","endTime":"0","summary":"Why the new GlaxoSmithKline contract matters for 4DMedical\n4DMedical (ASX:4DX) has drawn fresh attention after securing a one year engagement with GlaxoSmithKline to supply quantitative lung imaging analytics for pulmonary drug development and clinical research, in association with Flywheel Exchange.\nUnder the agreement, starting May 1, 2026, 4DMedical will provide advanced lung imaging biomarkers from its software analytics platform, supporting sensitive, quantitative assessment of lung...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/a-look-at-4dmedicals-valuation-after-new-glaxosmithkline-ima","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/a-look-at-4dmedicals-valuation-after-new-glaxosmithkline-ima","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631508657","title":"4DMedical's Year-to-Date Fiscal 2026 Operating Revenue Rises 12% Year on Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2631508657","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631508657?lang=en_us&edition=fundamental","pubTime":"2026-04-30 11:49","pubTimestamp":1777520988,"startTime":"0","endTime":"0","summary":"4DMedical  said the operating revenue for year-to-date fiscal 2026 was AU$5 million, up 12% compared to the prior corresponding period, with gross margins exceeding 90%, according to a Thursday Australian bourse filing.It reported operating revenue of AU$4.5 million in the prior-year period, according to a separate filing.Receipts from customers in the fiscal third quarter ended March increased 18% year-over-year to AU$1.4 million, from AU$1.2 million.Underlying software-as-a-service revenue was up 24% year-over-year for the nine months to March, driven by increased penetration across business-to-business software-as-a-service sites and distributors.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630732252","title":"4DMedical Says State Street Becomes Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2630732252","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630732252?lang=en_us&edition=fundamental","pubTime":"2026-04-28 14:27","pubTimestamp":1777357667,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) said State Street and its subsidiaries have become a substantial holder in the company on April 24 with a stake of 5.01% or 29.6 million shares, according to a Tuesday Australian bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","IE0034235188.USD","STT","BK4135","IE00BGHQF748.EUR","LU1883839398.USD","IE00B64PRP62.GBP","4DX.AU","LU0061475181.USD","LU1894683264.USD","BK4588","LU1894683348.USD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629585449","title":"A Look At 4DMedical’s (ASX:4DX) Valuation After Its New GlaxoSmithKline Lung Imaging Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2629585449","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629585449?lang=en_us&edition=fundamental","pubTime":"2026-04-24 01:08","pubTimestamp":1776964109,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) has secured a one-year contract with GlaxoSmithKline, in association with Flywheel Exchange, to supply quantitative lung imaging analytics for pulmonary drug development and clinical research starting May 1, 2026.\nSee our latest analysis for 4DMedical.\nThe GlaxoSmithKline agreement, recent inclusion in the S&P/ASX 200 Index and the upcoming AI & Technology Virtual Investor Conference sit alongside a share price of A$5.27, with a 30 day share price return of 13.82% and a 90...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/a-look-at-4dmedicals-asx4dx-valuation-after-its-new-glaxosmi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/a-look-at-4dmedicals-asx4dx-valuation-after-its-new-glaxosmi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIX","CHAT","BK4551","BK4588","BK4023","4DX.AU","BK4587","AIYY","AIPO","BK4528","BK4543","ARTY","BK4585","BK7094","AI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629256011","title":"Is 4DMedical's (ASX:4DX) ASX 200 Debut a Turning Point in Its Risk Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629256011","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629256011?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:11","pubTimestamp":1776838291,"startTime":"0","endTime":"0","summary":"4DMedical Limited (ASX:4DX) was added to the S&P/ASX 200 Index on 13 April 2026, marking its entry into Australia’s benchmark equities basket.\nThis index inclusion could broaden 4DMedical’s investor base as index-tracking funds and institutional portfolios reassess their exposure to the company.\nWe’ll now examine how 4DMedical’s addition to the S&P/ASX 200 may reshape its investment narrative and longer-term risk profile.\nFind 10 companies with promising cash flow potential yet trading below...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-asx-200-debut-a-turning-point-in-its-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/is-4dmedicals-asx4dx-asx-200-debut-a-turning-point-in-its-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","AIPO","AIYY","AI","BK4551","BK4528","4DX.AU","BK4587","CHAT","BK4588","BK4023","ARTY","TPB","BK4075","BK7094","AGIX","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628797243","title":"BRIEF-4Dmedical Executes Contract With Glaxosmithkline For Lung Imaging Analytics","url":"https://stock-news.laohu8.com/highlight/detail?id=2628797243","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628797243?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:31","pubTimestamp":1776648717,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Executes Contract With Glaxosmithkline For Lung Imaging AnalyticsApril 20  - 4DMedical Ltd 4DX.AX:4DMEDICAL LTD-GSK CONTRACT, UK CLEARANCE FOR CTVQ, AND ASX 200 INCLUSIONCT:VQ RECEIVES UKCA CERTIFICATION FOR CLINICAL USE IN UNITED KINGDOMEXECUTES CONTRACT WITH GLAXOSMITHKLINE FOR LUNG IMAGING ANALYTICSFurther company coverage: 4DX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nTUEQ7CKJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU1098665638.USD","LU0306806265.USD","LU0203347892.USD","IE0034235071.USD","LU0306807586.USD","SG9999001176.SGD","LU0971552830.HKD","LU1202635105.USD","LU1481600234.SGD","BK7094","LU0211331839.USD","LU0058720904.USD","LU1015430645.USD","LU0971552673.USD","LU1064927863.SGD","LU1228905037.USD","LU1487256676.USD","LU0545562505.USD","SG9999013999.USD","LU0225284248.USD","LU1481599808.USD","LU1035777561.USD","LU0575583348.USD","LU1309081286.SGD","LU1983299246.USD","LU1400636574.HKD","4DX.AU","SGXZ57979304.SGD","LU0161305163.EUR","GSK.UK","IE00BWDBJ516.SGD","LU1400636657.SGD","LU0225771236.USD","LU0557290698.USD","LU1400636491.USD","LU1645745479.HKD","IE00B3T34201.USD","LU1302929846.USD","LU0225283273.USD","LU0289739699.SGD","BK5011","SG9999001176.USD","IE00BQJZX424.USD","LU0109981661.USD","LU1670756490.USD","LU0321505868.SGD","LU0985481810.HKD","LU1228905540.USD","LU1046248800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628679753","title":"4DMedical Secures One-Year Deal With GlaxoSmithKline","url":"https://stock-news.laohu8.com/highlight/detail?id=2628679753","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628679753?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:16","pubTimestamp":1776647790,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) secured a one-year contract with GlaxoSmithKline, in collaboration with imaging data platform Flywheel Exchange, to provide its quantitative lung imaging analytics from May to supp","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144016744","title":"Stock Track | 4DMedical Soars 8.22% Intraday on GSK Contract, UK Certification, and ASX 200 Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1144016744","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144016744?lang=en_us&edition=fundamental","pubTime":"2026-04-20 08:03","pubTimestamp":1776643397,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock surged 8.22% during intraday trading on Monday, marking a significant upward movement for the medical imaging technology company.The sharp rise appears to be driven by multiple...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":88,"code":"91000000","status":"200"}]}}